Open-label infliximab for systemic lupus erythernatosus: long-term follow-up of 11 patients.

Aringer, Martin;Houssiau, Frédéric;Graninger, Winfried B.;Steiner, Guenter;Smolen, Josef S.
(2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: Washington (Dc) (10.November.2006)

Files

No attached file found for this publication.

Details

Authors
  • Aringer, Martin
    Author
  • Houssiau, FrédéricUCLouvain
    Author
  • Graninger, Winfried B.
    Author
  • Steiner, Guenter
    Author
  • Smolen, Josef S.
    Author
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Aringer, M., Houssiau, F., Graninger, W. B., Steiner, G., & Smolen, J. S. (2006). Open-label infliximab for systemic lupus erythernatosus: long-term follow-up of 11 patients. Arthritis & Rheumatism, 54(9), S260-S261. https://hdl.handle.net/2078.5/69455 (Original work published 2006)